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Abstract
Background: Studies on heteroplasmy occurring in the mitochondrial DNA (mtDNA) control
region (CR) in leukocytes of centenarians and younger subjects have shown that the C150T
somatic transition is over-represented in centenarians. However, whether the occurrence/
accumulation of heteroplasmy is a phenotypic consequence of extreme ageing or a genetically
controlled event that may favor longevity is a question that deserves further attention. To clarify this
point, we set up a Denaturing High Performance Liquid Chromatography (DHPLC) protocol to
quantify mtDNA CR heteroplasmy. We then analyzed heteroplasmy in leukocytes of centenarians
(100 subjects), their offspring and nieces/nephews (200 subjects, age-range 65–80 years, median age
70 years), and in leukocytes of 114 control subjects sex- and age-matched with the relatives of
centenarians.
Results: The centenarians and their descendants, despite the different ages, showed similar levels
of heteroplasmy which were significantly higher than levels in controls. In addition we found that
heteroplasmy levels were significantly correlated in parent-offspring pairs (r = 0.263; p = 0.009),
but were independent of mtDNA inherited variability (haplogroup and sequence analyses).
Conclusion: Our findings suggest that the high degree of heteroplasmy observed in centenarians
is genetically controlled, and that such genetic control is independent of mtDNA variability and
likely due to the nuclear genome.
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Mitochondrial DNA (mtDNA) is much more exposed to
mutagenic events than nuclear DNA (nDNA) due to its
high replication rate, lack of histone-like proteins, scarcity
of repair enzymes, and production of Reactive Oxygen
Species (ROS) which results from Oxidative Phosphoryla-
tion (OXPHOS) in mitochondria. The fate of heteroplas-
mic mutations depends on several factors, including type
and location of the variation, replication rate of the cell,
and also to chance since the mutant molecules can be ran-
domly lost as a consequence of mitochondria replicative
segregation. In any case, since mutations are stochastic
events, mtDNA heteroplasmy tends to increase with age.
Usually, a low level of heteroplasmy does not impair
mitochondrial function, but once the level of mutant
mtDNA exceeds a certain threshold, OXPHOS dysfunc-
tion may arise [1,2]. The cell tries to cope with such a
stressful condition by increasing OXPHOS, and therefore
producing ROS, in a vicious circle that may become lethal
to the cell itself.
As a rule, the age-related accumulation of mtDNA somatic
mutations leads to a decline in mitochondrial function,
which contributes to ageing and degenerative diseases
[3,4]. In fact, most of the literature on mtDNA somatic
mutations reports data on the role played by mtDNA het-
eroplasmy on age-related diseases, but recent findings
open a new perspective. Zhang et al. [5] carried out a
large-scale screening of the mtDNA main control region in
leukocytes from centenarians and younger controls. They
found that the C150T mutation is significantly more rep-
resented in centenarians than in younger controls, and
provided evidence that somatic events, probably under
nuclear genome control, contribute to the striking selec-
tive accumulation of this mutation in centenarians. In the
same report, using fibroblast longitudinal studies the
authors showed an age-related somatic expansion of the
mutation up to homoplasmy. Finally, 5' end analysis of
nascent heavy mtDNA strands revealed a new replication
origin at position 149, substituting the one at 151, only in
fibroblasts or immortalised lymphocytes carrying the
C150T mutation. On the whole, the data showed that a
high level of C150T heteroplasmy, possibly up to a new
homoplasmy arrangement, might be favourable for lon-
gevity. In agreement, a significant association between the
inherited C150T mutation and longevity has been
observed in both Finnish and Japanese populations [6].
The study by Zhang et al. [5] is of great value because it
indicates a possible beneficial effect on longevity by an
mtDNA somatic mutation able to restore the mitochon-
drial replication machinery. Therefore, it seemed worth-
while to further investigate possible links between
mtDNA CR heteroplasmy and longevity. Since longevity
shows clear patterns of familiarity [7,8], the study of such
a heteroplasmy in relatives of centenarians may help to
clarify the role of mtDNA somatic variability in longevity.
We set up a Denaturing High Performance Liquid Chro-
matography (DHPLC) protocol by which the hetero-
plasmy of an mtDNA CR fragment encompassing the
C150T mutation could be quantified. Then we compared
the levels of heteroplasmy between relatives of centenari-
ans (offspring and nieces/nephews) and age-matched
controls. Indeed, if heteroplasmy accumulates because of
age-related stochastic events, it should be similar between
age-matched groups regardless of the genetic relationship
with centenarians. On the contrary, if the heteroplasmy is
under genetic control, it should be higher in relatives of
centenarians than in controls. In this case, the hetero-
plasmy occurring in the mtDNA region under study may
be regarded as a contributing factor to familial recurrence
of longevity.
Results
DHPLC reference curve and sensitivity of the method
In order to quantify the levels of heteroplasmy in the bio-
logical samples under study, we applied DHPLC to artifi-
cial heteroplasmic samples and assembled the curve
shown in Fig. 1. The reference curve was used for estimat-
ing the levels of heteroplasmy in the biological samples.
In order to compare DHPLC and sequencing sensitivity in
revealing heteroplasmy, we submitted all the artificial
samples reported in Fig. 1 to sequence analysis. We found
that DHPLC is able to reveal up to 5% of heteroplasmy,
while the minimum level of heteroplasmy detectable by
sequence analysis is roughly 20–25%.
Before applying DHPLC to the biological samples, we ver-
ified that the PCR conditions were specific for the mtDNA
fragment under study (16531 nt-261 nt). No signal indi-
cating DNA amplification was observed by applying our
PCR protocol to DNA extracted from rho-zero cells (cells
depleted of mitochondria). Furthermore, the PCR primers
gave negative results to BLAST search.
Heteroplasmy in families of centenarians
DHPLC was then applied to PCR products of DNA
extracted from leukocytes of four sample groups: cente-
narians, offspring and nephews/nieces of centenarians,
and controls. Fig. 2 shows the distribution of the levels of
heteroplasmy in the four groups, as estimated using the
reference curve in Fig. 1.
Fig. 2 shows that approximately 15% of both centenarians
and their children, approximately 20% of nephews/nieces
of centenarians and more than 35% of controls display
levels of heteroplasmy lower than 2.5%. Therefore, notPage 2 of 10
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but the same occurs in their younger relatives.
We checked the statistical significance of the differences
shown in Fig. 2 by comparing the patterns of hetero-
plasmy between pairs of samples. Centenarians differed
from younger controls (p = 0.001) while they did not
from their relatives (p = 0.699 and p = 0.944 by compar-
ing centenarians with offspring and nieces/nephews,
respectively). What is more, the comparison between age-
matched groups revealed that heteroplasmy differed
between groups according to the presence/absence of a
centenarian in the family (p = 0.666 between offspring
and nieces/nephews of centenarians; p = 0.006 between
offspring of centenarians and controls; p = 0.003 between
nieces/nephews of centenarians and controls). The above
differences remained significant when the level of signifi-
cance was reduced to α = 0.009 (six independent compar-
isons).
The finding that the centenarians' offspring displayed a
heteroplasmic pattern similar to that of their very old par-
ents suggested that the level of mtDNA CR heteroplasmy
could be under genetic control. By linear regression anal-
ysis we confirmed a genetic control on this trait, as the lev-
els of heteroplasmy resulted significantly correlated in
parent-offspring pairs (Fig. 3; r = 0.263; p = 0.009).
Which genome (mtDNA or nDNA) could account for the
above results? In order to answer this question we parti-
tioned the group of parents according to sex (Fig. 4), and
found that the levels of heteroplasmy were significantly
correlated in mother-offspring pairs (r = 0.456; p = 0.001)
while there was no correlation in father-offspring pairs (r
= -0.053; p = 0.704).
The above result, which indicated a maternal genetic con-
trol, prompted us to search for a possible association
between inherited and epigenetic (somatic) mtDNA vari-
ability. Thus, we screened haplogroup and haplotype var-
iability in both centenarians and controls, and analyzed
the distribution of heteroplasmic subjects within each
haplogroup/haplotype category. The data are reported in
Tables 1 and 2.
Table 1: Inherited and epigenetic mtDNA variability. The number of subjects classified within a specific haplogroup is reported 
together with the number of subjects showing heteroplasmy levels higher than 5%. MtDNA haplogroups are classified according to 
Torroni et al., [27].
MtDNA Haplogroup Centenarians Controls
Absolute frequency Heteroplasmic subjects Absolute frequency Heteroplasmic subjects
H 35 15 34 10
I 2 2 0 0
J 11 8 17 7
K 10 6 16 6
T 6 3 10 3
U 13 7 11 4
V 1 1 1 0
W 2 1 4 3
X 9 8 5 3
Other 11 4 16 6
Total 100 55 114 47
DHPLC reference curve assembled from clones of mtDNA CR (16531 nt -261 nt) including either C150 or T150Figure 1
DHPLC reference curve assembled from clones of 
mtDNA CR (16531 nt -261 nt) including either C150 
or T150. The two clones were combined to generate sam-
ples having heteroplasmy levels of 0%, 5%, 10%, 20%, 30%, 
40%, 50 %. Het/Tot is the ratio between the height of the 
Heteroplasmic peak and the Total height of homoplasmic 
plus heteroplasmic peaks. Bars denote the standard deviation 
in triplicate experiments. The observed values were used to 
fit a 2nd degree polynomial function y = β1x + β2x2.Page 3 of 10
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within haplogroups (Table 1) or haplotypes (Table 2)
with the distribution expected under random association
between epigenetic and inherited variability, no signifi-
cant difference was found either in centenarians or in con-
trols (p > 0.2 by permutation tests).
In addition, we compared the pools of haplotypes (Table
2) between centenarians and controls by considering as
inherited the variant whose sequence peak was higher
than 80%. No significant difference was evident between
the groups (p = 0.999 by permutation test); therefore the
high heteroplasmy observed in centenarians was not due
to one or few haplotypes which could be particularly
prone to somatic mutations. On the whole, haplogroup
and haplotype analyses consistently indicated that
mtDNA CR heteroplasmy is independent of mtDNA
inherited variability.
The C150T somatic mutation
The DHPLC protocol used for assembling the reference
curve of Fig. 1 had been set up using mtDNA cloned frag-
ments that only differed in the C150T position. However,
when we deal with biological samples, we cannot exclude
that the DHPLC patterns of heteroplasmy we obtain
might be due to other heteroplasmic sites. To highlight
this point, first of all we carried out a careful visual inspec-
tion of every DHPLC profile in centenarians, their off-
spring, and controls. More than 60% of the samples
showed DHPLC profiles comparable with those obtained
with the different mixtures of C150 and T150 clones;
however other profiles were also observed, suggesting the
presence of additional heteroplasmic mutations in the
region under study. Thus we compared DHPLC profile
and sequence data whenever possible (requirement: min-
imum of 25% heteroplasmy). Out of 16 samples satisfy-
ing the requirement, we identified the six profiles reported
in Fig. 5, where the corresponding heteroplasmic muta-
tions detected by sequence analysis are also shown. Fur-
ther data on sequence analyses on DHPLC fractions
collected with a fraction collector are ongoing at present.
Table 3 summarises the proportion of different mutations
found in centenarians, their offspring and controls. The
C150T somatic mutation was present in 4 out of 7 cente-
narians, 4 out of 6 children of centenarians, and, in asso-
ciation with the T146C mutation, in 2 out of 3 controls.
Histograms showing mtDNA CR heteroplasmy in the four sample groupsFigure 2
Histograms showing mtDNA CR heteroplasmy in the four sample groups. Heteroplasmy is estimated from the 
DHPLC reference curve reported in Fig.1.Page 4 of 10
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The aim of the present study was to reconsider an intrigu-
ing observation: a strikingly high frequency of the C150T
mutation in mtDNA CR in centenarians [5]. The observa-
tion was at odds with the consolidated idea that hetero-
plasmy is detrimental for attaining longevity, considering
that a variety of mtDNA deletions and mutations accumu-
late with age [9] and that mitochondrial function declines
with age [10]. The novelty of our approach was to com-
pare mtDNA CR heteroplasmy in descendants of cente-
narians (both offspring and nephews/nieces) and age-
matched controls unrelated to centenarians. The analysis
of offspring of centenarians is a valuable tool in searching
for susceptibility genetic factors in longevity [11]; how-
ever, it has never been used to investigate a putative role
of mtDNA somatic variability on longevity.
The first requirement for our study was to set up a fast and
reliable method to screen mtDNA heteroplasmy, and
DHPLC met our requirement. Till now DHPLC has been
applied to detect mutations on the entire mtDNA mole-
cule in samples of rather limited size [12-16]. In our case,
we needed to carry out quantitative comparisons of the
level of heteroplasmy in a sole mtDNA region, the control
region, but in a large population sample (414 subjects in
total). The DHPLC protocol we set up provided reliable
results (see standard deviations of the reference curve in
Fig. 1) and was reasonably sensitive.
A further critical point was to establish that the PCR pro-
tocol was specific for the amplification of the 16531 nt-
261 nt mtDNA fragment. In fact, it was recently shown
that the pseudo-mitochondrial genome can induce errors
in heteroplasmy interpretation [17]. The negative results
we obtained both by processing rho-zero cells and by a
BLAST search excluded that nuclear pseudogenes contam-
inated mtDNA PCR amplifications.
Linear regression of heteroplasmy levels in parent-offspring pairs according to the sex of the parent: (a) male centenarian par-ents; (b) female centenarian parentsFigu e 4
Linear regression of heteroplasmy levels in parent-offspring pairs according to the sex of the parent: (a) male 
centenarian parents; (b) female centenarian parents. The regression lines showed r = -0.053 (p = 0.704) and r = 0.456 
(p = 0.001) in (a) and (b), respectively.
Linear regression between heteroplasmy levels in centenari-ans (x axis) and their offspring (y axis)Figu e 3
Linear regression between heteroplasmy levels in 
centenarians (x axis) and their offspring (y axis). Log 
transformed values were used in order normalise the distri-
bution. The regression line showed r = 0.263 (p = 0.009).Page 5 of 10
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Table 2: Variant sites found in mtDNA CR (16531 nt – 261 nt). For each haplotype the absolute frequency in centenarians (A) and 
controls (B) is reported. The number of subjects showing DHPLC heteroplasmy levels higher than 5% is reported in parenthesis. rCRS 


























































































rCRS A T T C T A A C G T C C T A C G A A A C T C T A T G T G T A G A T
A B
27(14) 18(3) - - - - - G - - - - - - - - - - - - - - - - - - - - - - - - - - -
2 (1) 0 - - - - C - - - - - - - - - - - - - - - - - - - - - - - - - - - -
3 (3) 0 - - - - - G - - - - - - - - - A G - - - - - - - - - - - - - A - -
21(8) 24(6) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
5 (3) 7 (4) - - - - - - - - - - - - C - - - - - - - - - - - - - - - - - - - -
1 (0) 0 - - - - - - G - - - - - - - - - - - - - C - - - - - - - - - - - -
1 (1) 2 (0) - - - - - G - - - - T - - - - - - - - - C - - - - - - - - - - - -
1 (1) 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - G -
1 (1) 0 - - - - - G - T - - - - - - - - - - - - - - - - - - - - - - - - -
1 (1) 7 (6) - - - - - G - - - - - - C - - - - - - - - - - - - - - - - - - - -
1 (1) 0 - - - - - G - - - - T - - - - - - G - - - - - - - - - - - - - - -
1 (1) 0 - - - - - G - - - C - - - G - - - - - - C - - - - - - A C - - - -
4 (4) 7 (1) - - - - - G - - - - - - - - - - - - - - C - - - - - - - - - - - -
1 (1) 0 - - - - - G - - A - - - - - - - - - - - C - - - - - - A C - - G -
1 (1) 2 (0) - - - - - G - - - - T - - - - - - - - - - - - - - - - - - - - - -
1 (0) 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - A - -
2 (2) 0 - - - - - G - - - - - T C - - - - - - - - - - - - - - - - - - - -
3 (1) 2 (2) - - - - - G - - - - - - - - - A - - - - - - - - - - - - - - A - -
1 (0) 0 - - - - - - - - - - - - - - - - - G - - - - - - - - - - - - - - -
1 (0) 0 - - - - - G - - - - - - - G - - - - - - C - - - - - - A C - - - -
1 (0) 0 - - - - - G - - A C - - C - - - - - - - C - - - - - - - - - - - -
2 (1) 0 - - - - - - - - - - - - - - - - - - - - - - - G - - - - - - - - -
1 (0) 0 - - - - - G - - - C - - C - - - - - - - - - - - - - C - - - - - -
1 (1) 6 (5) - - - - - G - - - - T - C - - - - - - - - - - - - - - - - - - - -
1 (1) 0 - - - T - G - - - - - - - G - - - - - - C - - - - - - A C - - - -
1 (0) 0 - C C - - - - - - - - - - - - - - - - - C - - - - - - - - - - - -
2 (1) 0 - - - - - - - - - - - T - - - - - - - - - - - - - - - - - - - - C
2 (0) 7 (1) - - - - - - - - - C - - - - - - - - - - - - - - - - - - - - - - -
1 (1) 0 - - - - - - - - - - T - - - - - - - - - - - - - - - - - - - - - -
1 (0) 0 - - - T - - - - - - - - - - - - - - - - C - - - - - - - - - - - -
1 (1) 0 - - - - - G - - - C - - - G - - - - - - C - - - - - - A - G - - -
1 (1) 2 (2) - - - - - G - - - - - - C - - - - - - C - - - - - - - - - - - -
1 (1) 0 - - - - - G - - - - - - - - - - - G - - C - - - C A - - - - - - -
1 (1) 0 - - - - C - G - - - T - - - - - - - - - C T - - - - - - - - - - -
1 (1) 4 (2) - - - - - G - - - C T - - - - - - - - - - - - - - - - - - - - - -
1 (1) 0 - - - - - G - - - - - - - - T - - - - - - - - - - - - - - - - - -
1 (0) 1 (0) - - - - - G - - - C - - - - - - - - - - - - - - - - - - - - - - -
1 (1) 0 - - - - - G - - - - T - - - - - - - - - C - - G - - - - - - - - -
0 2 (1) - - - - C - - - - - - T - - - - - - - - - - C - - - - - - - - - -
0 1 (0) - - - - - G - - - - - - - - - A - G - - - - - - - - - - - - A - -
0 1 (0) - - - - C - - - - - - T - - - - - - - - - - - - - - - - - - - - -
0 3 (3) - - - - - G - - - - - - C - - A G - - - - - - - - - - - - - - - -
0 1 (1) - - - - - - - - - C - - C - - - - - - - - - - - - - - - - - - - -
0 1 (1) - - - - - - G - - - - - - - - - - - - - - - - - - - - - - - - - -
0 1 (1) T - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
0 5 (2) - - - - - G - - - C - - - - - - - - - - C - - - - - - - - - - - -
0 2 (1) - - - - - G - - - C - - C - - - - - - - - - - - - - - - - - - - -
0 1 (0) - - - T C - - - - - - - - - - - - - - - C - - - - - - - - - - - -
0 1 (0) - - - - - G - - - - - - - - - A - - G - - - - - - - - - - - A - -
0 1 (0) - - - - C - - - - - - - - - - - - - - T - - - - - - - - - - - - -
0 2 (2) - - - - - G - - - - T - C - - - - - - - C - - - - - - - - - - - -
0 1 (1) - - - - - G - - - - - - - - - - - G - T C - - - - - - - - - - - -
0 1 (1) - - - - - G - - - - - - - - - - - G - - - - - - - - - - - - - - -
0 1 (1) - - - - - G - - - C T - C - - - - - - - - - - - - - - - - - - - -
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DHPLC profiles observed in the samples having levels of heteroplasmy equal to or higher than 25%Figure 5
DHPLC profiles observed in the samples having levels of heteroplasmy equal to or higher than 25%. The 
sequence which characterizes each profile is shown on the right.
BMC Genomics 2007, 8:293 http://www.biomedcentral.com/1471-2164/8/293The most important finding presented here is that the pat-
terns of mtDNA CR heteroplasmy do not differ between
centenarians and their descendants, but differ between
relatives of centenarians and age-matched controls (Fig.
2). This result ruled out that heteroplasmy was exclusively
due to age-related stochastic mutations, however indi-
cated that it was genetically controlled. In agreement, the
levels of heteroplasmy were significantly correlated in par-
ent-offspring pairs (Fig. 3). The observation that the corre-
lation was significant in mother-offspring pairs while not
in father-offspring pairs (Fig, 4a and 4b) suggested that a
possible genetic control on heteroplasmy was due to the
mitochondrial genome. However, other clues indicated a
different, and probably more complicated, genetic control
pattern. First, the lack of association between mtDNA
haplotypes and heteroplasmy (Tables 2 and 3) rules out
that there are mtDNA molecules more prone than others
to somatic mutations. Second, both the tissue specificity
of mtDNA CR point mutations [18] and the concordance
of heteroplasmy higher in monozygotic than in dizygotic
twins [5] denote that heteroplasmy is not related to the
mtDNA haplotype the offspring inherited from the
mother. Thus, although the genetic mechanism modulat-
ing the occurrence/accumulation of the mtDNA CR heter-
oplasmy needs further work to be elucidated, all the data
suggest the involvement of nuclear sex specific factors.
It should also be noted that the heteroplasmy revealed by
DHPLC does not refer to the sole C150T variability, but to
additional possible mutations occurring in the entire
16531 nt-261 nt mtDNA fragment. In fact, the C150T
mutation was found to be present in 10 out of 16 subjects
(Table 3), while the remaining subjects showed other het-
eroplasmic mutations [5]. Interestingly, most of the
observed heteroplasmic positions were either replication
origins (position 146, see Ref. [19]) or contiguous to rep-
lication origins (positions 150 and 152 that flank the 151
replication origin; position 189 which is 2 bp from the
191 replication origin). Since the C150T transition is able
to provide alternative replication origins [5], a similar
effect could be hypothesized for the other mutations.
The results reported in Fig. 2, show that mtDNA CR heter-
oplasmy cannot be accounted for only by to age-related
stochastic mutations. What is more, the finding that
mtDNA CR heteroplasmy is greater in descendants of cen-
tenarians than in age-matched controls suggests a benefi-
cial role of mtDNA heteroplasmy for attaining longevity.
In fact, several data show that the offspring of centenari-
ans have a better chance to attain longevity than the gen-
eral population [20,21]. How could this apparent paradox
be explained from a biological point of view? The well
known mitochondrial theory of ageing proposes that age-
associated mitochondrial dysfunction is a consequence of
age-associated accumulation of somatic mutations in the
mtDNA population. However, recent findings suggest that
at least some aspects of the above theory require reconsid-
eration [22]. In fact, a key for explaining the paradox that
mtDNA heteroplasmy could be beneficial for longevity
may be the new emerging concept of mitochondria com-
plementation, which suggests that human cells are pro-
tected from mitochondrial dysfunction by
complementation of mtDNA products in fused mitochon-
dria [23]. The beneficial effect of complementation may
be enhanced by efficient mtDNA replication, as provided
by CR mutations which introduce alternative replication
sites. In fact, multiple replication origins falling in this
DLoop region could play a major role in accelerating
mtDNA synthesis to satisfy developmental, physiological,
or aging-related demands [19]. However, neither the rep-
licative advantage of some variants nor the mitochondrial
complementation can explain, by themselves, the hetero-
plasmy patterns of Fig. 2. By contrast, it is likely that the
interplay among new replication origins, mitochondrial
complementation and nuclear factors might provide an
advantage for pursuing longevity by counteracting age-
related mitochondrial damages. In this frame, the subjects
who are genetically predisposed to mtDNA CR hetero-
plasmy would be clearly favoured in the demographic
selection as defined by Perls et al. [24].
Conclusion
By studying offspring and nephews/nieces of centenarians
we have shown that mtDNA CR heteroplasmy is geneti-
cally controlled and it recurs in families of centenarians.
This observation suggests a beneficial role of mtDNA het-
eroplasmy for attaining longevity and it may provide indi-
rect evidence to the complementation of mitochondria in
coping with age-related mitochondrial dysfunc-
tion.Methods
Table 3: Heteroplasmic sites identified by sequencing mtDNA 
CR (16531 nt_261 nt) in subjects showing DHPLC heteroplasmy 















Centenarians 1 1 4 1
Offspring of centenarians 1 4# 1
Controls 2* 1
# One of the 4 children showing C150T heteroplasmy was the son 
of one of the 4 centenarians displaying C150T heteroplasmy.
* Subjects showing heteroplasmy for both T146C and C150T 
mutations.Page 8 of 10
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A total of 414 subjects were analyzed: 100 trios composed
of one centenarian, his/her child, his/her nephew/niece
plus a control group of 114 unrelated subjects with no cen-
tenarian in the family. The age range in each of the four
sample groups was as follows: 100–108 years in centenar-
ians (median age 100 years, 53 males and 47 females);
65–80 years in offspring of centenarians (median age 70
years; 42 males and 58 females) as well as in nephews/
nieces of centenarians (median age 70 years, 51 males and
49 females) and in the control group (median age 71
years, 50 males and 64 females). All subjects lived in
Calabria (southern Italy) and their Calabrian ancestry was
ascertained up to the grandparents' generation. The sam-
pling was carried out in the frame of the ECHA research
project [25]. All the subjects provided written informed
consent for the use of their phenotypic and genetic data in
studies on human ageing.
Molecular analyses
Total DNA was extracted from blood buffy-coats follow-
ing standard procedures.
1. PCR amplification
A 300 bp region of mtDNA encompassing the C150T site
(region 16531-261) was amplified by 5'-AAT-
AGCCCACACGTTCCCCTTA-3' forward primer and 5'-
GCTGTGCAGACATTCAATTG-3' reverse primer (0,4 µM
each) in a final volume of 25 µl, containing 100 ng DNA,
1.5 mmol/L MgCl2, 200 µmol/L of each dNTP, and 1 U of
EuroTaq DNA polymerase (EuroClone). Amplification
was performed in a Perkin Elmer Cetus 9600 PCR system.
The amplification conditions were as follows: initial dena-
turation at 93°C for 30s, followed by 35 cycles at 93°C for
15s, 64°C for 20s, 72°C for 1 m. PCR products were
checked by 2% agarose gel electrophoresis in TBE buffer
with ethidium bromide staining.
2. DHPLC
After PCR fragments had been denatured for 3 m at 95°C,
and gradually re-annealed from 95°C to 65°C in 30 m, 15
µl of each sample were injected onto a DNASep™ column
of a Transgenomic Wave Nucleic Acid Fragment Analysis
System (Transgenomic, San Jose, CA). The amplicons
were eluted in 0.1 M triethylammonium acetate, pH 7,
with a linear acetonitrile gradient at a flow rate of 0.9 ml/
min. Temperature conditions were chosen according to
the online program provided by Stanford University [26].
Mismatches were recognised by the appearance of two or
more peaks in the elution profiles. The heights of DHPLC
peaks were measured by using WAVEMAKER 4.0 software
(Transgenomic San Jose).
3. Quantification of heteroplasmy levels
PCR products containing common (C150) and mutant
(150T) sequences were cloned into a plasmid vector
pGEM-T Easy by using the TA cloning kit (Invitrogen,
USA) according to the manufacturer's protocol. The cor-
rect insertion of the PCR product was verified by sequence
analysis.
In order to build a reference curve for measuring the levels
of heteroplasmy in the biological samples, plasmids con-
taining the common (C150) and the mutant (150T)
sequences were mixed in different proportions (0% C
with 100% T; 5% C with 95% T; 10% C with 90% T; 20%
C with 80% T; 30% C with 70% T; 40% C with 60% T;
50% C with 50% T) and again subjected to PCR amplifi-
cation. Using this approach, artificial samples having con-
trolled conditions of C150T heteroplasmy were created.
These samples were then subjected to DHPLC and a refer-
ence curve was assembled where the ratio between the
height of the heteroduplex peak and that of the total peak
was reported as a function of heteroplasmy, which varied
according to the proportion between the two categories of
cloned plasmids. The levels of heteroplasmy in the biolog-
ical samples were then estimated on the reference curve.
4. Sequencing
PCR-amplified fragments were purified by QIAquick PCR
purification Kit (Qiagen), and sequenced by fluorescence-
based automated direct sequencing using a BigDye Termi-
nator Cycle Sequencing Ready Reaction Kit in a 310 DNA
sequencer (PE Applied Biosystems). Sequencing reaction
mixtures contained 4 µl of Terminator Ready Reaction
Mix, 200 ng of template, 3.2 pmol of each primer in a
total volume of 20 µl. Cycle sequencing was carried out
for 25 cycles at 96°C for 10s, 50°C for 5s, 60°C for 4 m
in GeneAmp PCR system 9600. The extension products
were purified using Centri-Sep™ spin columns (Princeton
Separations).
Statistical analysis
SPSS v.10 software (SPSS Inc., Chicago, IL, USA) was used
for statistical analysis. Non-parametric two-sided Mann-
Whitney-U test was used to verify if the patterns of heter-
oplasmy were different between sample groups. The level
of significance was adjusted to α = 1-0,951/n, where n rep-
resents the number of independent comparisons.
Permutation tests were used to verify if the population
pools of mtDNA haplotypic sequences (region 16531-
261) differed between the sample of centenarians and that
of younger controls with no centenarian in the family.
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